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Membranes made of several diﬀerent materials are available in the market, nonresorbable (e.g. ePTFE), resorbable (e.g. synthetic
or collagen) and liguid applicable (e.g. Polyethylene glycol or Atrisorb). The purpose of the present study was to evaluate whether
or not in situ application of Atrisorb could be used as a barrier membrane for guided bone regeneration. Ten patients with
insuﬃcient alveolar ridge width for implant placement participated in the study. Atrisorb in conjunction with various bone grafts
was used to treat 10 diﬀerent sites, 3 sites treated prior to implant placement and 7 sites in conjunction with implant placement.
Augmented sites were allowed to heal for 3 to 7 months, with mean healing time of 4.7 months. Healing was uneventful with no
major complications. Two sites experienced a ﬂap dehiscence accompanied by barrier exposure during the initial healing period.
Secondaryhealingwasachieved soonafter withno signsofinfection,givingAtrisorb a barrier exposure rateof20%forthepresent
study, which corresponds to favorably to that of resorbable membranes. The liquid membrane has the potential of being a viable
alternative to traditional resorbable membranes for use in GBR procedures.
1.Introduction
Several techniques have been suggested for the regener-
ation of a deﬁcient alveolar ridge segment. Traditionally,
guided bone regeneration (GBR) derives its principles from
guided tissue regeneration (GTR). Epithelial and gingival
connective tissue cell exclusion, biocompatibility, adequate
blood supply, space maintenance, wound stability, and ease
of use of a barrier membrane are required for predictable
tissue regeneration [1]. Space maintenance is harder to
obtain in staged GBR procedures than GTR procedures.
GTR relies on the remaining bony walls and teeth to help
maintain space for cellular ingrowth and regeneration. In
GBR procedures, however, there is a lack of direct support
from the surrounding tissues. Therefore, the outcome of
GBR depends more on membrane stability, primary ﬂap
closure, and postoperative compliance [2].
Many diﬀerent types of barrier membranes are avail-
able on the market today. These are nonresorbable (e.g.,
ePTFE), resorbable (e.g., synthetic or collagen), and liquid
applicable (e.g., polyethylene glycol or Atrisorb). Reports in
t h el i t e r a t u r eh a v ep r o v e nt h ee ﬃcacy of both resorbable
and nonresorbable membranes to exclude soft tissue cells
from invading a grafted defect and promote substantial bone
regeneration [3–5]. Unfortunately, there are a number of
complications that have been reported with the use of these
traditional membranes for regenerative procedures, (e.g.,
exposure, infection, and collapse), especially with nonre-
sorbable membranes [6, 7]. Sometimes, these complications
c a u s ef a i l u r eo ft h er e g e n e r a t i v ep r o c e d u r e[ 8, 9].
Atrisorb (DL-lactide polymer, Atrix Laboratories Inc.,
Fort Collins, Colo USA) has been used as a barrier mem-
brane, and proven successful for periodontal regeneration
[10–12]. Since GBR is based on the principals of GTR, it is
reasonable to suggest that Atrisorb can function as a barrier
membrane for guided bone regeneration procedures as well.
But because it is dispensed in a liquid form, it may be more
challenging than traditional membranes to handle during
regenerative procedures.
The purpose of this study was to determine the potential
of an in situ application technique of Atrisorb to be used
as a barrier membrane for guided bone regeneration in2 ISRN Dentistry
Figure 1: Paracrestal incision edentulous sites number 30 and
number 31 for access to alveolar bone.
achieving adequate horizontal bone regeneration for pros-
theticallydrivenimplant placement.This study also aimed to
evaluate the ease of use and technique sensitivity of a liquid
membrane compared to a traditional membrane.
2.Materialsand Methods
Data were retrospectively collected from ten consecutive
patients with insuﬃcient alveolar ridge width for implant
placement (no permission from institutional review board
human studies committee required). Patients were in good
health and had no contraindications to surgical therapy. All
patientsunderwent a completeoral exam and formulationof
a comprehensive treatment plan prior to surgery. Diagnostic
wax-upsandsurgicalstentswere usedasneededtoplanridge
augmentation for future prosthetically driven restorations.
Presurgical preparation included extensive oral hygiene
instructions and treatment to eliminate active periodontal
disease, if necessary.
Prior to surgery patients were given 2 grams of
amoxicillin and rinsed with a 0.1% aqueous solution of
chlorhexidine. All surgical procedures were performed as
outpatient procedures under local anesthesia (lidocaine with
1:100,000epi). Atrisorb in conjunction with various bone
grafts was used to treat 10 diﬀerent sites, 3 sites treated
prior to implant placement and 7 sites in conjunction
with implant placement (Table 1). All surgical procedures
consisted of full thickness ﬂaps, with paracrestal incisions
made towards the lingual aspect of the ridge in keratinized
gingiva (Figures 1 and 2). Vertical releasing incisions were
placed providing the ﬂap with a large base and allowing
access to the defect. Following ﬂap reﬂection, any residual
soft tissue was removed with curettes, and sutures were used
to laterally position ﬂaps as needed. Defects were assessed
for adequate buccal lingual width for prosthetically driven
implant placement. If ridge width was adequate for implant
placement and primary stabilization, implant placement
and grafting was performed (three out of ten cases). If
ridge width was inadequate for implant placement and
primary stabilization, only bone grafting was performed. In
all cases, multiple cortical perforations were made on the
buccal and crestal bone with a number 8 round carbide
Figure 2: Full-thickness ﬂaps are reﬂected. Buccal ridge defect is
evident.
Figure 3: Following placement of implants, bone graft material is
placed and Atrisorb liquid is easily applied.
bur under copious irrigation. This was done to provide an
increase of blood supply and access of progenitor cells to
the regenerative site. Various bone grafting materials were
then placed and condensed into the defect. Ridge defects
were overﬁlled to compensate for any shrinkage during
graft maturation. The surgical ﬁeld was isolated from saliva
contact, ensuring a hemostatic ﬁeld. Atrisorb barrier was
then applied over the bone graft using an in situ method,
making sure to entirely cover the particulate and the margins
of the graft (Figure 3). Apical undermining of the ﬂap
allowed for primary closure and tension-free adaptation of
the ﬂap over the grafted area. Horizontal mattress sutures in
combination with single interrupted and continuous sutures
were placed to allow tension-free closure of the ﬂap. Patients
were not permitted to wear removable prosthesis over the
surgical area until complete healing and graft maturation
had occurred. Patients (received prescription for one week
of antibiotic coverage with) were prescribed amoxicillin
500mg po bid for one week and appropriate analgesics as
needed. Patients were also instructed to rinse with 0.12%
chlorhexidine rinse twice a day for two weeks.
3.Results
A total of sixteen implants were placed at the grafted sites.
All ﬁndings are displayed in Table 1. Average healing timeISRN Dentistry 3
Table 1: Intraoperative evaluation, materials, and outcomes.




1M 7 H M + B O 5 Y
2F 3 0 H C + B O 3 . 5 Y
3 F 7, 10 H M + BO 5 Y
4F 2 0 H C + B O 4 Y
5 F 29, 30 H BO 4 Y 2 weeks
6F 1 9 H C + B O 4 N
7 F 18, 19 H M 5 Y
8F 2 1 H M + B O 6 Y
9 F 13, 14, 15 H C 3 N
10 M 29, 30 H A + C 7 N 3 weeks
H= Horizontal ridge defect.
Graft material: M= MTF(FDB), BO= Bio-Oss, A= Autogenous, C= Cerasorb.
Figure 4: Exposure to Atrisorb at 2 weeks. Notice the lack of
epithelialization in the area of exposure.
was 4.7 months (range: 3.5 to 7 months) before restorative
procedure began. Upon reentry for implant placement, the
augmented tissue appeared as mineralized bone tissue and
Atrisorb seemed to retain its structural integrity. In all of
the sites which were augmented prior to implant placement,
the bone volume following regeneration was adequate for
implant placement. Remnants of Atrisorb were noted in all
sites, proving its substantivity of at least 3 months. Survival
rate of implants at the grafted sites is 100%. All implants
have been in function for 32 months. There has not been
anysigniﬁcant marginal bonelossaroundtheimplantsin the
grafted sites.
Two sites experienced complications limited to ﬂap
dehiscence and exposure of barrier material, resulting in
an exposure rate of 20%. One patient (case 5) had a
circular shaped exposure on the crest that appeared 2 weeks
after surgery (Figure 4). This patient was treated with
0.12% chlorhexidine rinse, and after six weeks there was
epithelialization over the exposed barrier (Figure 5), and no
further complications or infection was noted (Figures 6, 7,
and 8). A second patient (case 10) had a circular shaped
crestal exposure at 3 weeks. The patient had some loss of
graft material and barrier material during the exposure.
Figure 5: After treatment with chlorhexidine rinse, reepithelializa-
tion over the grafted site is evident.
Figure 6: Occlusal view at time of uncovery showing increase in
ridge width.
The patient was treated with 0.12% chlorhexidine rinse,
and epithelialization of the exposed graft site was noted by
six weeks. No other complications with healing were noted
during the healing process. A minor loss of bone grafts
was noticed where there was exposure during the healing
phase.4 ISRN Dentistry
Figure 7: At time of uncovery, Atrisorb material is still intact.
Figure 8: Final restorations in place.
4.Discussion
A total of ten sites were treated with a GBR procedure
using Atrisorb as a barrier membrane in combination with
diﬀerent grafting materials. The outcome oftreatment for all
siteswas foundtobesuccessful.Allsites showedregeneration
of bone to allow for successful implant placement. This
clinical case series demonstrates the potential eﬃcacy of
Atrisorb as a barrier membrane for a GBR procedure.
Additionally, in the surgeon’s (D. Kim) experience,
Atrisorb was easier to handle and more convenient to use
than traditional membranes. There was no need to spend
time trimming a membrane prior to placement, and there
was no concern about the stability of the membrane during
ﬂap closure and during the healing period. The Atrisorb
liquid was applied quickly and precisely over the bone graft
material, and there was no shifting of the membrane during
ﬂap closure.
Substantivity of a membrane is essential for guided
bone regeneration. Histological analysis has shown that the
kinetics of cell population were greatest during ﬁrst 2 weeks
and subsided by 21 days [13]. Bone maturation continues
after the early months following an augmentation surgery
[14]. Therefore, in GBR, it is necessary not only to maintain
the barrier function for at least 3 weeks, but also to retain
its function for at least a few months during the period of
bone maturation. In the present study, it was observed that
Atrisorb was still present after 3 months.
Another critical factor in regenerative procedures is
space maintenance. Even though Atrisorb itself has enough
physical strength to maintain its integrity underneath a ﬂap,
it cannot be used alone since it does not have suﬃcient
strength to maintain adequate space for regeneration [15].
In order to overcome this limitation, Atrisorb is applied
over bone grafting particulate so that it congeals with the
particulateand bindstotheadjacent bone.This combination
results in a material that provides both physical strength
and space-maintaining ability. The results of the present
study demonstrated that Atrisorb combined with various
bone grafts was able to prevent collapse of the grafted site
from ﬂap pressure during the healing process and provide
adequate space for regeneration of new bone for proper
implant placement.
Although both resorbable and nonresorbable mem-
braneshaveproventobepredictableoptionsforguidedbone
regeneration, they have certain limitations. Nonresorbable
membranes (e.g., ePTFE) are prone to higher exposure
rates [3] and must be removed if exposed [16]. Resorbable
membranes (e.g., synthetic or collagen) sometimes suﬀer
from early degradation and an inﬂammatory response
during degradation [17]. Exposure of these membranes can
jeopardize the regenerative potential of the grafted site.
Studies have shown that except for Ossix membranes,
most resorbable membranes were not recovered by soft
tissue after being exposed [18]. The frequency of soft tissue
dehiscence over Atrisorb was comparable to biodegrad-
able membranes and obviously better than nondegradable
membranes when used in GBR [3]. Like biodegradable
membranes, Atrisorb liquid barrier can experience prema-
ture soft tissue dehiscence and exposure, but this does not
necessarily jeopardize the regenerative potential of the GBR
procedure. In the present study, the two cases with exposure
of Atrisorb during healing recovered spontaneously with
soft tissue coverage after weeks of irrigation with 0.12%
chlorhexidine and oral hygiene. The exposures were not
associated with any signs of infection, nor did they cause any
signiﬁcant complicationswith boneregenerationorinterfere
with implant placement.
The applicationoftraditional membranes is knownto be
very technique sensitive. These membranes must be cut and
adapted properly to the surgical site to reduce the chance of
exposure, and often tacks or sutures are necessary to stabilize
the membrane during the healing process, since any shifting
of the membrane may compromise its ability to maintain
space. Because Atrisorb is a liquid, its application is fast and
eﬃcient. There is no need to cut the membrane to ﬁt the
grafted area, and no trimming of sharp edges is necessary
to reduce chances of exposure. The bioadhesive nature of
liquid Atrisorb enables it to adhere directly to the teeth and
surrounding bone. This eliminates the need for tacks and
stabilizing sutures. In the present study, the Atrisorb barrier
did not shift during repositioning and suturing of the ﬂaps.
This observation reassured the surgeon that the membrane
covered the entire grafted site, maximizing its function as a
barrier membrane. It should be noted that isolation of the
graft area from blood and saliva prior to application of the
Atrisorb barrieris crucialinordertoachieve propercoveringISRN Dentistry 5
of the particulate graft and adherence to surrounding
structures. The present study demonstrated the ease of use
of the Atrisorb liquid membrane in GBR techniques.
5.Conclusion
The results of this study indicate that Atrisorb can be used
for GBR procedures and that it has the potential to be a
viablealternativetotraditionalnonresorbableandresorbable
membranes for use in GBR procedures. In this paper, the in
situ application of Atrisorb in conjunction with bone grafts
successfully achieved an increase in alveolar ridge width.
It was also observed that hard tissue augmentation was
n o tc o m p r o m i s e dd e s p i t et h ef a c tt h a tt h em e m b r a n ew a s
exposedtotheoralenvironmentforsome time.Additionally,
the handling of Atrisorb is more convenient when compared
to traditional membranes. Future larger scale clinical and
histologicstudiesshouldbeconductedtosupporttheclinical
ﬁndings presented in this study.
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